Reckitt Benckiser Group Plc vs Unilever plc: Which Should You Buy?

Results today show Reckitt Benckiser Group Plc (LON: RB) is making progress. How does it compare to rival, Unilever plc (LON: ULVR)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

reckitt.benckiserToday’s update from Reckitt Benckiser (LSE: RB) showed that the company is making progress with its goal of increasing revenue by 5% per annum. Indeed, it believes that the best way to achieve this is to de-merge its pharmaceuticals arm into a separate, standalone company so that Reckitt Benckiser can focus on improving sales of hygiene, health and consumer products. This seems to make sense, especially since the company has cautioned that the second half of the year could see demand weaken due to a tough climate in the US and certain emerging markets.

UnileverThis sentiment was echoed by rival Unilever (LSE: ULVR) (NYSE: UL.US), which said in its recent update that it is experiencing pricing pressure in developed countries and a general slowdown in demand in Asia. Despite this, shares have posted strong gains in 2014, being up 5% versus just 1% for the FTSE 100, although they are some way behind Reckitt Benckiser’s 9% increase during 2014. Looking ahead, which of the two companies is the better investment?

Growth Potential

Despite both companies reporting disappointing levels of demand in emerging markets, Reckitt Benckiser and Unilever both have vast potential when it comes to long-term sales growth. Indeed, on this front, Unilever could have the edge, since its products tend to be more luxurious and more discretionary than many of Reckitt Benckiser’s. This could allow Unilever to take advantage of increasing wealth levels and the rapid growth in the middle class in emerging markets to a greater extent than Reckitt Benckiser.

Even in the short term, Unilever’s forecast growth in earnings is higher than that of Reckitt Benckiser. For instance, while Unilever is set to report growth in earnings per share (EPS) of just 1% this year, the company is expected to bounce back next year with growth of 9%. Reckitt Benckiser, meanwhile, is forecast to deliver a reduction in earnings of 6% this year, followed by growth of 5% next year.

Valuations

As two companies with considerable long-term potential, as well as a stable of highly lucrative brands, Unilever and Reckitt Benckiser are unlikely to ever be cheap. Indeed, their current price to earnings (P/E) ratios are 20.2 (Reckitt Benckiser) and 20.3 (Unilever). Although marginally higher, Unilever seems to offer better value than its peer as a result of its higher forecast growth rate, but also because it pays a higher yield. While Reckitt Benckiser’s yield is just 2.6%, Unilever currently yields 3.4%, which is in-line with the market average.

Looking Ahead

Indeed, when it comes to which is the better buy, Unilever seems to edge out Reckitt Benckiser. That’s because, while its current valuation is slightly higher, it appears to offer superior short and long term growth prospects to its rival, as well as a higher yield. While both companies could have strong futures, Unilever could have the slightly brighter one for investors.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool owns shares of Unilever.

More on Investing Articles

Investing Articles

5 steps to start buying shares with under £500

Learn how this writer would start buying shares with a few hundred pounds in a handful of steps, if he…

Read more »

Young happy white woman loading groceries into the back of her car
Investing Articles

The FTSE 100 offers some great bargains. Is this one?

Our writer digs into one FTSE 100 share that has had a rough 2024 to date, ahead of its interim…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

£9,000 of savings? Here’s my 3-step approach to aim for £1,794 in passive income

Christopher Ruane walks through the practical steps he would take to try and turn £9,000 into a sizeable passive income…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

I’d buy 29,412 shares of this UK dividend stock for £150 a month in passive income

Insiders have been buying this dividend stock, which offers an 8.5% yield. Roland Head explains why he’d choose the shares…

Read more »

Red briefcase with the words Budget HM Treasury embossed in gold
Investing Articles

Could the new UK budget spell growth for these 6 FTSE stocks? I think so!

Mark David Hartley considers six UK stocks that could enjoy growth off the back of new measures announced in the…

Read more »

Investing Articles

With a 6.6% yield, is now the right time to add this income stock to my ISA?

Our writer’s looking to boost his Stocks and Shares ISA. With this in mind, he’s debating whether to buy a…

Read more »

Dividend Shares

This blue-chip FTSE stock just fell 12.5% in a day. Is it time to consider buying?

Smith & Nephew is a well-known, blue-chip FTSE stock with a decent dividend yield. And its share price just dropped…

Read more »

Investing Articles

At 72p, the Vodafone share price looks to be at least 33% undervalued to me

Our writer looks at a number of valuation measures to determine whether the Vodafone share price reflects the fair value…

Read more »